Cargando…

Role of fatty liver in coronavirus disease 2019 patients’ disease severity and hospitalization length: a case–control study

BACKGROUND AND PURPOSE: Fatty liver is one of the most common pre-existing illnesses; it can cause liver injury, leading to further complications in coronavirus disease 2019 patients. Our goal is to determine if pre-existing fatty liver is more prevalent in hospitalized COVID-19 patients compared to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziaee, Arash, Azarkar, Ghodsiyeh, Ziaee, Masood
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474852/ https://www.ncbi.nlm.nih.gov/pubmed/34565475 http://dx.doi.org/10.1186/s40001-021-00590-y

Ejemplares similares

Analysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case–Control Study
por: Azarkar, Ghodsiyeh, et al.
Publicado: (2019)

Prevalence of Bone Density Reduction and Its Related Factors in Hemophilia Patients in South Khorasan Province in 2018
por: Ehsanbakhsh, Alireza, et al.
Publicado: (2020)

Genotyping and Mutation Pattern in the Overlapping MHR Region of HBV Isolates in Southern Khorasan, Eastern Iran
por: Ziaee, Masood, et al.
Publicado: (2016)

Assessing the Prevalence of Ectopic Cerebellar Tonsils and Accompanying Symptoms in Individuals with Various Headaches
por: Azarkar, Ghodsiyeh, et al.
Publicado: (2023)

Ceftriaxone-associated nephrolithiasis and gallstone in adults
por: Azarkar, Ghodsiyeh, et al.
Publicado: (2018)

Prevalence of Hepatitis D Virus Infection Among Patients With Chronic Hepatitis B Attending Birjand Hepatitis Clinic (East of Iran) in 2012
por: Ziaee, Masood, et al.
Publicado: (2013)

The prevalence of HTLV-1 and its Co-Infection with HCV, HBV and HIV in Hemophilic patients
por: Ziaee, Masood, et al.
Publicado: (2015)

Fitting logistic regression models to assess vitamin D deficiency with clinical parameters in chronic hepatitis B patients
por: Osmani, Freshteh, et al.
Publicado: (2021)

Clinical characteristics and risk factors for mortality in COVID-19 inpatients in Birjand, Iran: a single-center retrospective study
por: Azarkar, Ghodsiyeh, et al.
Publicado: (2021)

Persistence of immunity to hepatitis B vaccine as infants, 17 years earlier
por: Azarkar, Zohreh, et al.
Publicado: (2018)

Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study
por: Hajiaghamohammadi, Ali Akbar, et al.
Publicado: (2012)

Evaluation of vancomycin use in university-affiliated hospitals in Southern Khorasan Province (East Iran) based on HICPAC guidelines
por: Mahi-Birjand, Motahare, et al.
Publicado: (2019)

Severe Falciparum Malaria in Iran: A Very Rare Case From an Endemic Region
por: Ziaee, Masood, et al.
Publicado: (2014)

SARS-COV-2 IgG specific antibodies persistence in recovered COVID-19 individuals and its association with severity and time of illness
por: Pagheh, Abdol Sattar, et al.
Publicado: (2023)

Seroprevalence of SARS-COV-2 antibodies among health-care workers exposed to COVID-19 patients in a large reference hospital, Iran
por: Pagheh, Abdol Sattar, et al.
Publicado: (2022)

Coronavirus disease 2019 and non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2021)

Association of metabolic‐associated fatty liver disease and risk of severe coronavirus disease 2019 illness
por: Sy‐Janairo, Marianne Linley, et al.
Publicado: (2020)

Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
por: Vasques-Monteiro, Isabela Macedo Lopes, et al.
Publicado: (2021)

Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran
por: Ziaee, Masood, et al.
Publicado: (2016)

The Impact of Nonalcoholic Fatty Liver Disease on the Outcomes of Coronavirus Disease 2019 Infection
por: Asemota, Joseph, et al.
Publicado: (2022)

Interaction of metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019
por: Vázquez‐Medina, Martín Uriel, et al.
Publicado: (2022)

Association between the Hepatic Lipase Promoter Region Polymorphism (-514 C/T) and the Presence and Severity of Premature Coronary Artery Disease
por: Goodarzynejad, Hamidreza, et al.
Publicado: (2017)

Nurses’ consultative role to health promotion in patients with chronic diseases
por: Yousefi, Hojatollah, et al.
Publicado: (2019)

The rs5888 single nucleotide polymorphism in scavenger receptor class B type 1 (SCARB1) gene and the risk of premature coronary artery disease: a case-control study
por: Goodarzynejad, Hamidreza, et al.
Publicado: (2016)

The effect of low serum calcium level on the severity and mortality of Covid patients: A systematic review and meta‐analysis
por: Alemzadeh, Effat, et al.
Publicado: (2021)

Dynamic Changes, Cut-Off Points, Sensitivity, and Specificity of Laboratory Data to Differentiate Macrophage Activation Syndrome from Active Disease
por: Assari, Raheleh, et al.
Publicado: (2015)

Cholesteryl ester transfer protein gene polymorphism (I405V) and premature coronary artery disease in an Iranian population
por: Goodarzynejad, Hamidreza, et al.
Publicado: (2016)

Coronavirus Disease-2019 and Implications on the Liver
por: Campbell, Patrick T., et al.
Publicado: (2023)

Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
por: Xu, Yanlan, et al.
Publicado: (2021)

Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019
por: Buckley, Leo F., et al.
Publicado: (2020)

Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
por: Gao, Feng, et al.
Publicado: (2021)

Is Fatty Liver Associated with Increased Mortality and Morbidity in Coronavirus Disease 2019 (COVID-19) Pneumonia?
por: Madan, Kaushal, et al.
Publicado: (2022)

Clinical characteristics of Coronavirus Disease 2019 and development of a prediction model for prolonged hospital length of stay
por: Hong, Yucai, et al.
Publicado: (2020)

The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
por: Liu, Tao, et al.
Publicado: (2020)

The role of a cytokine storm in severe coronavirus disease 2019 in pregnancy
por: Wang, Xiaoping, et al.
Publicado: (2020)

Pathogenesis of Liver Injury in Coronavirus Disease 2019
por: Kumar, Pramod, et al.
Publicado: (2020)

Coronavirus Disease-2019 (COVID-19) and the Liver
por: Elhence, Anshuman, et al.
Publicado: (2021)

Comorbidities and severity of coronavirus disease 2019 patients
por: Radwan, Nashwa M., et al.
Publicado: (2020)

Severe Hepatitis in Pediatric Coronavirus Disease 2019
por: Antala, Swati, et al.
Publicado: (2022)

A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019
por: Zhang, Fengqin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pda9qkfrgiptlvpehjbupq44ao